Susquehanna International Group, LLP Better Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.14 - $0.39 $5,327 - $14,842	38,057 New	38,057 $7,000
Q1 2023 May 16, 2023	SELL	$0.64 - $1.45 $4,142 - $9,385	-6,473 Reduced 11.99%	47,516 $33,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $1.74 $19,224 - $30,409	-17,477 Reduced 24.45%	53,989 $59,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $2.77 $4,718 - $8,542	3,084 Added 4.51%	71,466 $126,000
Q2 2022 Aug 15, 2022	BUY	$0.91 - $2.34 $62,227 - $160,013	68,382 New	68,382 $107,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.